Congress Presentations
Stay informed about the latest scientific and medical research from Axsome.
SLEEP 2024
Houston, TX | June 01 - 05, 2024
Sunosi® | Excessive Daytime Sleepiness
Dr. Hans P. A. Van Dongen, PhD describes the “Effects of Solriamfetol on Cognition in Obstructive Sleep Apnea With Excessive Daytime Sleepiness and Impaired Cognition” APSS 2024 poster
Sunosi® | Excessive Daytime Sleepiness
Effects of Solriamfetol on Cognition in Obstructive Sleep Apnea With Excessive Daytime Sleepiness and Impaired Cognition
Sunosi® | Excessive Daytime Sleepiness
Plenary Presentation: Effects of Solriamfetol on Cognition in Obstructive Sleep Apnea With Excessive Daytime Sleepiness and Impaired Cognition
Sunosi® | Excessive Daytime Sleepiness
Effects of Solriamfetol on Cognition in Patients With Excessive Daytime Sleepiness Associated With Narcolepsy
Sunosi® | Excessive Daytime Sleepiness
Plenary Presentation: Effects of Solriamfetol on Cognition in Patients With Excessive Daytime Sleepiness Associated With Narcolepsy
Sunosi® | Excessive Daytime Sleepiness
SURWEY: Treatment of Excessive Daytime Sleepiness With Solriamfetol: Initiation, Titration, and Outcomes
Sunosi® | Excessive Daytime Sleepiness
Real-world Use of Solriamfetol for Excessive Daytime Sleepiness in Patients Reporting Anxiety or Depression
Sunosi® | Excessive Daytime Sleepiness
Solriamfetol and Maintenance of Wakefulness Outcomes in Patients With Narcolepsy and Obstructive Sleep Apnea
